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Summary
Objectives: In chronic rhinosinusitis (CRS), SinoNasal Outcome Test-16 (SNOT-16) is a speciﬁc
quality of life (QoL) questionnaire, validated in English and existing in a French translation.
The present study assessed the psychometric characteristics of the French translation in nasal
polyposis (NP).
Methods: The QoL of 40 NP patients was assessed before and after endoscopic ethmoidectomy,
with the generic Study Short Form 36 (SF-36) and the speciﬁc SNOT-16 questionnaires.
Results: SF-36 scores were improved 1 year postoperatively. The SNOT-16 Cronbach 
coefﬁcient was 0.81. In the preoperative course, SNOT-16 scores correlated with the men-
tal composite score ([MCS]: P = 0.034; rho =−0.36) and the role-physical ([RP]: P = 0.02;
rho =−0.39), vitality ([VT]: P = 0.008; rho =−0.44) and role-emotional ([RE]: P = 0.035;
rho =−0.36) dimensions of the SF-36. SNOT-16 scores were poorer in women (P = 0.03) and
in case of aspirin intolerance (P = 0.044). SNOT-16 scores were signiﬁcantly lower 1 year after
surgery (P = 0.0017).
Conclusion: The SNOT-16 seemed, in the present series, to be a reliable, valid and sensitive
questionnaire. Validation on a larger series could enable its use in the French NP population to
ness
. All
Aassess the precise effective
© 2010 Elsevier Masson SASIntroduction
In nasal polyposis (NP), during the last decade, attention
has focused on the assessment of symptoms and especially
of quality of life (QoL) impact. The European Academy of
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llergology and Clinical Immunology (EAACI) has validated a
ethod of overall symptom intensity assessment on a visual
nalog scale (VAS), from 0 to 10 cm [1]. QoL questionnaires
ssess either general health (GH) status (generic question-
aires) or speciﬁc pathology-related health status (speciﬁc
uestionnaires). Generic questionnaires enable the QoL of
patient suffering from a given illness to be compared to
hat of patients with other pathologies or of pathology-free
ubjects in the general population. The Medical Outcomes
tudy Short Form 36 (SF-36) questionnaire is the most widely
sed, and has been validated pre- and postoperatively in
served.
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hronic rhinosinusitis (CRS) (levels of proof IIa and IIb). Seve-
al speciﬁc questionnaires assessing QoL in CRS have been
ublished and assessed in their English-language versions.
he RhinoSinusitis Outcome Measure (RSOM) comprises 31
tems and takes 20minutes to complete. The SinoNasal
utcome Test-20 (SNOT-20), derived from the RSOM, has
een validated and is used in medical and surgical studies
levels of proof Ib and IIb). The SNOT-16, also derived from
he RSOM, has been translated and made usable in a Cana-
ian French version; it is the only CRS-speciﬁc questionnaire
vailable in French, based on North American studies, but
as yet to be assessed and validated in France.
As measurement tools, QoL questionnaires are characte-
ized by their psychometric features, i.e.:
reliability (or precision), assessed by internal coherence,
or the correlation between scores on different question-
naire items measuring the same attribute;
validity (or relevance), assessed by comparison with
another, already validated, QoL gold standard;
sensitivity to change, or the method’s ability to reﬂect
perceptible variations, whether spontaneous (due to the
natural evolution of the disease) or induced (by treat-
ment).
The present study tested the SNOT-16 questionnaire,
ssessing QoL in patients followed for NP. Its psychometric
roperties were assessed against SF-36 data as gold stan-
ard.
atients and methods
prospective study, run from January 2007 to January 2009,
ncluded 40 patients followed for primitive NP resistant to
ell-conducted medical treatment (maximal dose topical
orticotherapy and failure of at least three courses of
eneral corticotherapy), in whom endoscopic endonasal eth-
oidectomy was performed.
All patients provided written consent and were inter-
iewed on the eve of surgery to assess preoperative QoL on
he generic SF-36 and CRS-speciﬁc SNOT-16 questionnaires.
The SF-36 is a self-administered questionnaire compri-
ing 36 questions grouped into eight dimensions or scales,
ach corresponding to a certain aspect of health status:
hysical functioning (PF), role-functioning (physical) (RP),
odily pain (BP), general health (GH), vitality (VT), social
unctioning (SF), role-functioning (emotional) (RE) and men-
al health (MH). Responses to each of the 36 questions are
eighted to deﬁne the scores on each of the eight dimen-
ions. These eight scores are then linearized to provide
transformed score of between 0 and 100. A minimum
core corresponds to limited health, and a maximum score
100) to absence of disease-related limitations. Factorial
nalysis of the eight SF-36 scales deﬁnes two composite
cores: themental composite score (MCS), combining dimen-
ions VT/SF/RE/MH, and the physical composite score (PCS),
ombining dimensions PF/RP/BP/GH, both calculated by
tandardization of the transformed scores on the relevant
imensions by speciﬁc weighting coefﬁcients, applicable to
ny population [2].
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The SNOT-16 is a self-administered questionnaire com-
rising 16 questions. Its French version is available on the
ashington University in Saint-Louis School of Medicine web-
ite: http://oto2.wustl.edu/clinepi. Responses are scored
s: 0 = no bother, 1 =mild or minor bother, 2 =moderate
other, 3 = severe bother. Patients are also asked to check
o ﬁve items which are most important to them personally.
cores range from 0 (no functional bother) to 48 (maximal
unctional bother) [3].
All 40 patients were followed up in the department at
east 1 year postoperatively for QoL assessment. Meanwhile,
hey had been receiving local mometasone furoate (100
o 200g/d); no general corticotherapy was prescribed.
atients needed to be contacted once or several times
or them to come to this assessment session. The generic
F-36 and the speciﬁc SNOT-16 questionnaires were used.
ostoperative data harvesting lasted from January 2008 to
anuary 2009.
Statistical analysis used MedCalc® software (Maria-
erke, Belgium). Means for independent nonmatched groups
ere compared by nonparametric Kruskall Wallis and Mann
hitney tests, and for matched groups by nonparamet-
ic Wilcoxon test. Correlation analysis was by parametric
earson test for continuous variables and by nonparame-
ric Spearman test for discrete variables. The signiﬁcance
hreshold was set at P≤ 0.05 for all tests. The rho correlation
oefﬁcient was used; internal QoL questionnaire coherence
as assessed by the Cronbach alpha coefﬁcient, with values
reater than 0.8 indicating good internal coherence.
esults
opulation
orty patients were included: 23 male (58%) and 17 female
42%). Median age was 54 years (range: 16—72 yrs). NP
as isolated in 22 cases (55%), associated with asthma
n 11 (27.5%) and part of a Fernand-Widal triad in seven
17.5%). Seventeen patients (42.5%) were sensitized to
ne or more allergens. Seventeen (42.5%) had undergone
revious endonasal polypectomy (6/17) or ethmoidectomy
11/17).
re- and postoperative generic Study Short Form
6 quality of life assessment
ll 40 patients completed the preoperative SF-36 question-
aire.
Median physical (PCS) and MCS were respectively
5.6/100 (range: 23.4—62.2) and 39.9/100 (range:
0.6—58.6). The eight SF-36 dimension scores were all
ower than those of the disease-free general population,
nd especially as regards the RP and SF dimensions (Fig. 1).
Twenty-eight postoperative SF-36 questionnaires could
e analyzed. PCS, MCS and all eight dimensions tended to
how improvement at 1 year postoperatively, and signiﬁ-
antly so for MCS (P = 0.01), SF (P = 0.0006) and MH (P = 0.05)
Table 1). Subgroup analysis by gender, clinical form, his-
ory of polypectomy or ethmoidectomy did not alter these
ndings.
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aFigure 1 Preoperative Study Short Form 36 score. Comparison
[2].
Speciﬁc Study Short Form-36 quality of life
assessment: psychometric properties
Reliability
The Cronbach alpha coefﬁcient for the preoperative SNOT-
16 scores of the 40 patients was 0.81, indicating good
internal coherence (> 0.8).
ValidityThe median preoperative SNOT-16 score was 22/38 (range:
3—38). Preoperative SNOT-16 scores correlated signiﬁ-
cantly with MCS (P = 0.034; rho =−0.36), the RP (P = 0.02;
rho =−0.39), VT (P = 0.008; rho =−0.44) and RE (P = 0.035;
rho =−0.36) dimensions (Fig. 2).
Table 1 Pre- and postoperative Study Short Form 36 scores
(median).
Preoperative (/100) Postoperative (/100) P
PCS 45.6 49.2 0.46
MCS 39.9 48.6 0.01*
PF 80 80 0.89
RP 50 75 0.29
BP 56.5 72 0.06
GH 52 57 0.2
VT 50 55 0.44
SF 50 75 0.006*
RE 66.6 100 0.17
MH 60 68 0.05
MCS: mental composite score; PCS: physical composite score;
PF: physical functioning; RP: role-functioning (physical); BP:
bodily pain; GH: general health; VT: vitality; SF: social function-
ing; RE: role-functioning (emotional); MH: mental health (MH).
*P < 0.05: signiﬁcant.
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Iedians with normal values in the general population (N = 3,617)
ensitivity to change
he median preoperative SNOT-16 score was signiﬁcantly
igher in women (23/38) than men (18/38) (P = 0.03), and
lso in case of NP associated with aspirin intolerance
30/38) than in isolated NP or in case of associated asthma
20/38) (P = 0.044). No such difference was associated with
llergy (P = 0.19) or history of polypectomy or ethmoidec-
omy (P = 0.46).
Median SNOT-16 score was signiﬁcantly reduced at follow-
p of at least 1 year after endonasal surgery in the 28
nalyzable cases: 22/48 preoperatively, 13/48 postopera-
ively (P = 0.0017).
iscussion
P and CRS in general are frequent pathologies of major
mpact on the population as a whole. CRS affects 5 to 15%
f the urban population in Europe and North America [4—8],
ith 18 to 22m consultations in the USA [9] and a health-care
ost estimated at $2.4 bn [7]. The socioeconomic impact
s signiﬁcant, in terms of productivity loss and time off
ork [8]. Functional signs (nasal obstruction, rhinorrhea,
ysosmia) can be assessed efﬁciently by physicians, but the
hysical, mental, emotional, social and professional impact
s underestimated. QoL assessment tools are thus required
o measure impact and assess the effectiveness of medical
nd surgical management [4].
Subjective QoL assessment is based on standardized
uestionnaires. These may be generic, assessing overall
ealth status and enabling comparison between different
atient groups and with the general, supposedly healthy,
opulation, or speciﬁc, assessing symptom impact on physi-
al and mental status in a given pathology [4]. Several
eneric questionnaires are available for adult (Short Form-
6 Health Survey, McGill Pain Questionnaire, Glasgow Beneﬁt
nventory) and child patients (Child Health Questionnaire).
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Figure 2 Correlations between preoperative SinoNasal Outcome Test-16 score and preoperative Study Short Form 36 scores for
m lity.
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iental composite score, role-physical, role-emotional, and vita
n 1991, the International Quality of Life Assessment (IQOLA)
roject translated the SF-36 for 15 countries, including
rance. The SF-36 is now a reliable, valid and reproductible
eference tool [4]. Several CRS-speciﬁc questionnaires have
lso been validated. The RSOM-31 assesses symptom inten-
ity and subjective impact on 31 items [4]. The SNOT-20,
erived from the RSOM-31, comprises 20 items that are
asy to implement and are sensitive to change [4,5,10]. The
NOT-16 is a reduced, 16-item version of the SNOT-20; tested
n 47 patients by Anderson et al., it proved reliable, valid and
ensitive [3]. It has been translated into French and Spanish
or wider use, but has yet to be scientiﬁcally validated in
rance for application in clinical practice.
Many studies of CRS, with or without polyps, have used
he SF-36 [6,8,11—15]. All highlighted the major impact
f this pathology in comparison to normal values for the
eneral population [11,14,15]. The present study conﬁrmed
hese ﬁndings, with lower preoperative scores on the eight
F-36 dimensions than in the general French population.
urgery-related stress may have to some extent biased these
esults, inﬂating values harvested at eve of surgery. The
ost strongly affected dimensions were RP, BP, GH, VT and
F, in agreement with previous reports in CRS [8,12,15]. QoL
mpact is, indeed, more severe in CRS than in other chronic
ffections such as high blood pressure, bronchitis or lower
ack pain [4,7,8,16].
a
d
a
tThe improvement in QoL following surgical treatment of
RS with polyps was found to be signiﬁcant in most studies
sing the SF-36 [6,8,12,14,15,17]. The present study con-
rmed this, with scores tending to improve in all dimensions,
ut signiﬁcantly so only on the SF and MH scales and the MCS;
ur small series may account for the failure of the other
tems to attain signiﬁcance. QoL improvement is conserved
ver time: the present follow-up was of more than 1 year,
s in several other reports [12,14,16]. Videler found func-
ional results to be stable at 2 years in a series of 23 patients
7]. Postoperative scores, however, remain lower than in the
eneral population, conﬁrming the impact, however mode-
ate, of residual symptoms [12].
The present study assessed the psychometric properties
f the SNOT-16; results, however, remain preliminary, in the
bsence of any previous French clinimetric study.
Reliability (Cronbach alpha) in terms of homogeneity
f measurement criteria was estimated at 0.81 in our
0 patients. Anderson et al. reported a comparable value
f 0.89 in 47 CRS patients [3]. Alpha greater or equal to 0.7
s the prerequisite for use of the test in clinical practice [3].The validity of the SNOT-16 was assessed preoperatively
gainst SF-36 scores: the correlation was signiﬁcant for three
imensions (RP, RE, VT) and for MCS: i.e., for both physical
nd mental parameters. Anderson et al. reported correla-
ions with seven of the eight SF-36 dimensions [3,13]. That
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the present correlations were less strong may have been
due to sample size. The SNOT-16 score assesses the phys-
ical and emotional impact of sinonasal pathology on QoL.
Discriminatory validity is another way of testing the ques-
tionnaire’s validity: it is deﬁned as an instrument’s ability to
distinguish patient groups with and without the pathology of
interest. It was not assessed in the present study; Anderson
et al., however, compared 47CRS patients with 14 patients
followed for otologic pathology, thereby deﬁning a refe-
rence mean SNOT-16 score of 10.5 for a CRS-free popula-
tion, signiﬁcantly different from that found in the CRS group
[3].
The sensitivity of a questionnaire is assessed in terms of
the ability to distinguish distinct pathological states. This
is an essential parameter for identifying different patient
groups and assessing treatment efﬁcacy [4].
In the present study, the preoperative SNOT-16 score
was poorer in women and in case of aspirin intolerance;
allergy was not a relevant factor. Other parameters have
been assessed in the literature, using other speciﬁc ques-
tionnaires. Davis et al. reported poorer SNOT-16 scores in
case of depressive disorder [16]. Mace et al. reported similar
ﬁndings using the RhinoSinusitis Disability Index (RSDI) [18].
McMains and Kountakis reported poorer preoperative SNOT-
20 scores in case of asthma [10]. These results are quite
variable, but conﬁrm the sensitivity of the tests used to com-
pare different patient groups. Speciﬁc questionnaires have
also been used to compare objective and subjective parame-
ters in CRS [9,10,11,17,19,20]. Thus, no correlation emerged
between Lund-Mackay CT scores and QoL. This ﬁnding high-
lights the interest of prior QoL assessment in indicating NP
surgery. In infectious CRS, however, the situation is diffe-
rent: infection site evolution on imaging takes precedence
over improvement in QoL in deciding on treatment indica-
tions.
SNOT-16 is sensitive in assessing treatment efﬁcacy. In the
present study, the SF-36 score improved after surgery. The
fall in SNOT-16 score was statistically signiﬁcant (P = 0.0017),
conﬁrming the SF-36 ﬁndings and highlighting the efﬁcacy
of surgical management of functional impairment. Other
studies have reported similar ﬁndings using SNOT-16 [16,17]
and SNOT-20 [5,10,21,22].
The SNOT-16 questionnaire met the three psychometric
criteria for use in clinical practice. These results are, how-
ever, to be interpreted with caution, in view of the small size
of the present series. Implementation was found to be sim-
ple and well accepted by patients. One drawback of SNOT-16
and SNOT-20 often pointed out in the literature is that they
do not assess dysosmia or nasal obstruction, which are major
symptoms in NP; an 11-item questionnaire including these
two parameters, the SinoNasal Assessment Questionnaire-11
(SNAQ-11) [23] has been developed, but has yet to undergo
psychometric assessment.
ConclusionNP is a disabling chronic pathology. Functional impact, with
its physical, emotional and socioeconomic consequences,
determines therapeutic decision-making. IQOLA using the
SF-36 showed lasting improvement in the experience of NP
patients at more than 1 year postoperatively.
[95
QoL assessment methods need to be easier to use in order
o standardize management assessment. The present study
ested the SNOT-16 questionnaire: it appeared to be a reli-
ble, valid and sensitive tool. Larger scale evaluation should
dentify its psychometric properties more precisely with a
iew to validation for clinical practice.
onﬂict of interest
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